Geistlich Ortho

Geistlich Ortho Geistlich is specialised in biomaterials for the regeneration of bone and cartilage.

An inspiring day at the IBRA Master Course in Basel! ✨A big thank you to the IBRA Institute for the outstanding collabor...
07/11/2025

An inspiring day at the IBRA Master Course in Basel! ✨

A big thank you to the IBRA Institute for the outstanding collaboration and the excellent, well-organized IBRA Master Course “Challenges in Foot and Ankle Surgery”. 🙌

Special thanks to the Chairman Victor Valderrabano and to all the faculty for the excellent topics covered, the interesting case presentations, and the nice discussions that made the day really engaging. 💬

Among the many insightful topics discussed, it was great to see the Geistlich Chondrogide Membrane included in the context of foot and ankle surgery.

Events like this continue to push the boundaries of innovation and excellence in surgical education. 👏

Geistlich is proud to be a partner of the IBRA Master Course: Challenges in Foot & Ankle Surgery!📍 Basel | November 7–8,...
20/10/2025

Geistlich is proud to be a partner of the IBRA Master Course: Challenges in Foot & Ankle Surgery!

📍 Basel | November 7–8, 2025

Hosted at the IBRA Institute, this advanced two-day course—led by Prof. Dr. med. Dr. phil Victor Valderrabano and an international faculty—combines in-depth theory with hands-on training, featuring expert-led discussions and practical exercises for a comprehensive learning experience.

✅ For detailed information and registration, please visit:
🔗 https://www.ibra.net/events/$/Challenges-in-Foot-Ankle-Surgery/620

🚨 Exciting Clinical Milestone🦵 OrthoPure®XT from Tissue Regenix Group is a safe, off-the-shelf product in ACL Reconstruc...
02/10/2025

🚨 Exciting Clinical Milestone

🦵 OrthoPure®XT from Tissue Regenix Group is a safe, off-the-shelf product in ACL Reconstruction!

The first-in-human 5-year clinical study of a novel porcine xenograft for ACL reconstruction has just been published in the Journal of Experimental Orthopaedics.

✅ Key Highlights:
- 40 patients treated with a decellularized porcine tendon graft
- No immunogenic response observed
- Clinical outcomes comparable to autografts and allografts
- Graft ruptures limited to young male patients
- MRI and radiographic results support safety and performance

This study marks a significant step forward in expanding graft options for ACL surgery, offering a biomechanically sound and immunologically safe alternative.

📄 Read the full publication in our bio!

Contact us for more information ➡️ gpag.ortho@geistlich.ch

Cartilage Image of the month – September 2025 🍁🍂🖼️ Selected as the Cartilage Image of the Month September, this case was...
29/09/2025

Cartilage Image of the month – September 2025 🍁🍂

🖼️ Selected as the Cartilage Image of the Month September, this case was submitted by Dr. Andrejs Finogejevs (LV).
A 42-year-old active female office worker presented with pain, stiffness, and limited knee motion for two months (VAS 4–6). Conservative treatment included NSAIDs and a knee brace. Imaging revealed a 1.5 x 2.5 cm cartilage defect on the medial femoral condyle.

Dr. Finogejevs performed a mini-open chondroplasty and microfracture. At 6 months post-op, the patient reported no pain, had returned to sports activities, and was fully weight-bearing without crutches.

At 6 months post-op, the patient was pain-free, active in sports, and walking without crutches. The one-year follow-up image shows a well-filled defect, with cartilage regeneration reaching the level of the surrounding tissue—indicating a successful outcome and excellent tissue remodeling.

Adresse

Bahnhofstrasse 40
Wolhusen

Öffnungszeiten

Montag 08:00 - 12:00
13:00 - 17:00
Dienstag 08:00 - 12:00
13:00 - 17:00
Mittwoch 08:00 - 12:00
13:00 - 17:00
Donnerstag 08:00 - 12:00
13:00 - 17:00
Freitag 08:00 - 12:00
13:00 - 17:00

Telefon

+41414925555

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Geistlich Ortho erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Geistlich Ortho senden:

Verknüpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Kategorie

About us

Geistlich Surgery produces innovative bio-derived matrix products for bone and cartilage, including Orthoss®, Orthoss Collagen®, and Chondro-Gide®. Our products leverage the body’s own healing potential to regenerate bone and cartilage. Our focus is on helping people maintain and regain their quality of life.

Geistlich Surgery is a business unit of Geistlich Pharma AG, which is headquartered in Switzerland. Entirely family owned since 1851, the company develops, produces, and markets medical devices for regenerative medicine and pharmaceuticals. From research and development to marketing, our operations are fully integrated under one roof, which enables us to oversee and optimize all levels of our business.